Novo Nordisk A/S | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (101)

View All

Latest Posts

About This Stock More About This Stock
The Weight Loss Market Can Surge To $400B By 2032, And These Stocks Will Rule It
Article By: The Tokenist
Friday, July 12, 2024 1:40 PM EDT
Despite Novo Nordisk's momentum, Eli Lilly seems a better long-term bet. Pfizer could surprise everyone from an undervalued position.
In this article: LLY, NVO, PFE
Read
Will NVO Provide Any Buying Opportunity?
Article By: Elliottwave Forecast
Monday, July 8, 2024 5:35 AM EDT
Novo Nordisk A/S, a healthcare company engages in the research, development, manufacture & marketing of the pharmaceutical products worldwide.
In this article: NVO
Read
Week In Review: Fosun Pharma Plans $690 Million Deal To Privatize Henlius, Its Biologics Subsidiary
Article By: ChinaBio® Today
Sunday, June 30, 2024 1:20 PM EDT
Shanghai Henlius Biotech agreed to be a wholly owned subsidiary of Fosun in a $690 million deal that values the company at $1.7 billion. Meanwhile, Suzhou Ascentage Pharma filed to list in the US to support its portfolio of drugs.
In this article: NVO, CASI, CHRS, IVBXF, ASPHF
Read
Novo Nordisk Wins Approval For Its Weight-Loss Drug From China
Article By: Wajeeh Khan
Tuesday, June 25, 2024 10:41 AM EDT
China approved the sale of Novo Nordisk's Wegovy on Tuesday. The drugmaker also announced a $4.1 billion investment in the U.S. Novo Nordisk stock climbed 3.0% to an all-time high this morning.
In this article: NVO
Read
Lawsuit Could Challenge Trust In Ozempic And Other Popular Weight Loss Drugs
Article By: The Conversation
Friday, June 21, 2024 9:32 AM EDT
Weight loss drug manufacturers Novo Nordisk and Eli Lilly are being challenged in court. The companies are accused of failing to properly warn patients about associated risks.
In this article: NVO, LLY
Read
All Posts

Latest Tweets for $NVO

No tweets yet!

PARTNER HEADLINES